Holen Sie sich die Stockscreener-App
2.33
5.67%
-0.14
Handel nachbörslich:
2.20
-0.13
-5.58%
Schlusskurs vom Vortag:
$2.47
Offen:
$2.47
24-Stunden-Volumen:
70,323
Relative Volume:
0.21
Marktkapitalisierung:
$7.78M
Einnahmen:
$556.00K
Nettoeinkommen (Verlust:
$-5.28M
KGV:
-1.0888
EPS:
-2.14
Netto-Cashflow:
$-6.23M
1W Leistung:
-6.80%
1M Leistung:
-1.38%
6M Leistung:
-8.98%
1J Leistung:
-8.81%
1-Tages-Spanne:
$2.26
$2.50
1-Wochen-Bereich:
$2.17
$2.59
52-Wochen-Spanne:
$1.27
$9.4699
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
Firmenname
Cyclerion Therapeutics Inc
Sektor
Branche
Telefon
617-621-7722
Adresse
301 BINNEY STREET, CAMBRIDGE, MA
Vergleichen Sie CYCN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CYCN
Cyclerion Therapeutics Inc
|
2.33 | 7.91M | 556.00K | -5.28M | -6.23M | -2.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-20 | Eingeleitet | Truist | Buy |
| 2021-09-24 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2019-06-03 | Eingeleitet | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc Aktie (CYCN) Neueste Nachrichten
Leading vs lagging indicators on Cyclerion Therapeutics Inc. performanceIndex Update & Free Community Supported Trade Ideas - newser.com
Will Cyclerion Therapeutics Inc. stock recover faster than peers2025 Stock Rankings & Daily Stock Momentum Reports - newser.com
Published on: 2025-10-09 06:28:37 - newser.com
Is Cyclerion Therapeutics Inc. stock ready for a breakoutJuly 2025 Final Week & Growth-Oriented Investment Plans - newser.com
Published on: 2025-10-09 05:00:18 - newser.com
Detecting support and resistance levels for Cyclerion Therapeutics Inc.2025 Support & Resistance & Verified Chart Pattern Trade Signals - newser.com
Pattern recognition hints at Cyclerion Therapeutics Inc. upsideJuly 2025 Selloffs & Trade Opportunity Analysis Reports - newser.com
What MACD signals say about Cyclerion Therapeutics Inc.July 2025 Decliners & Growth Oriented Trading Recommendations - newser.com
Trend Bullish continuation from March 2025Sector-Based Investing & Rapid Portfolio Strategies - earlytimes.in
Best data tools to analyze Cyclerion Therapeutics Inc. stockJuly 2025 PostEarnings & Long Hold Capital Preservation Tips - newser.com
Will Cyclerion Therapeutics Inc. stock recover after recent dropJuly 2025 Technicals & Verified Entry Point Signals - newser.com
Cyclerion Therapeutics Inc. stock volume spike explainedTrade Signal Summary & Short-Term High Return Strategies - newser.com
Will Cyclerion Therapeutics Inc. price bounce be sustainableJobs Report & Short-Term Swing Trade Alerts - newser.com
How to use a screener to detect Cyclerion Therapeutics Inc. breakouts2025 Retail Activity & Technical Buy Zone Confirmations - newser.com
What drives Cyclerion Therapeutics Inc stock pricePortfolio Diversification Tips & Affordable Market Trading - earlytimes.in
Cyclerion Therapeutics Inc Stock Analysis and ForecastStock Price Forecasts & In-Depth Analyst Ratings Explained Simply - Early Times
Why Did Cyclerion Therapeutics Stock Surge Nearly 50% After-Hours Today? - MSN
Real time scanner hits for Cyclerion Therapeutics Inc. explainedInsider Buying & Free Verified High Yield Trade Plans - newser.com
Cyclerion Therapeutics’ Licence Move: Boost or Bust? - StocksToTrade
Hengrui, Glenmark ink ADC deal; Rome Therapeutics to seek ‘strategic options’ - Endpoints News
Why Is Cyclerion Stock Surging In Pre-market Trade? - Nasdaq
Full technical analysis of Cyclerion Therapeutics Inc. stockPortfolio Value Summary & Verified Swing Trading Watchlist - newser.com
Finanzdaten der Cyclerion Therapeutics Inc-Aktie (CYCN)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):